Thymidine and Thymine Incorporation into Deoxyribonucleic Acid: Inhibition and Repression by Uridine of Thymidine Phosphorylase of Escherichia coli

Por Budman, Daniel R., Pardee, Arthur B.
Publicado em 1967

Novel microtubule-targeting agents – the epothilones

Por Cheng, Kit L, Bradley, Thomas, Budman, Daniel R
Publicado em 2008

Trastuzumab-DM1: A Clinical Update of the Novel Antibody-Drug Conjugate for HER2-Overexpressing Breast Cancer

Por Barginear, Myra F, John, Veena, Budman, Daniel R
Publicado em 2012

Identification of unique synergistic drug combinations associated with down expression of survivin in a preclinical breast cancer model system

Por Budman, Daniel R., Calabro, Anthony, Rosen, Lisa, Lesser, Martin
Publicado em 2012

Poly(ADP-Ribose) Polymerase-1 Inhibition: Preclinical and Clinical Development of Synthetic Lethality

Por Leung, Mary, Rosen, David, Fields, Scott, Cesano, Alessandra, Budman, Daniel R
Publicado em 2011

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

Por Berry, Donald A., Cirrincione, Constance, Henderson, I. Craig, Citron, Marc L., Budman, Daniel R., Goldstein, Lori J., Martino, Silvana, Perez, Edith A., Muss, Hyman B., Norton, Larry, Hudis, Clifford, Winer, Eric P.
Publicado em 2006

Adjuvant ovarian function suppression and cognitive function in women with breast cancer

Por Phillips, Kelly-Anne, Regan, Meredith M, Ribi, Karin, Francis, Prudence A, Puglisi, Fabio, Bellet, Meritxell, Spazzapan, Simon, Karlsson, Per, Budman, Daniel R, Zaman, Khalil, Abdi, Ehtesham A, Domchek, Susan M, Feng, Yang, Price, Karen N, Coates, Alan S, Gelber, Richard D, Maruff, Paul, Boyle, Frances, Forbes, John F, Ahles, Tim, Fleming, Gini F, Bernhard, Jürg
Publicado no Br J Cancer (2016)